FAM66C Gene

Name family with sequence similarity 66, member C
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n FAM66C is a long non‐coding RNA that displays context‐dependent roles across different disease models. In glioma, its expression is downregulated compared to non‐tumor samples, and loss‐of‐function studies indicate that FAM66C acts as a tumor suppressor by functioning as a competing endogenous RNA (ceRNA) that modulates the Hippo signaling pathway through interactions with miR‑15a/miR‑15b and the downstream effector LATS1, thereby restraining cell proliferation and migration."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In rheumatoid arthritis, a genome‐wide expression quantitative trait loci analysis in CD4⁺ T cells identified a significant cis‐eQTL for FAM66C, suggesting that its regulation might contribute to the genetic architecture and activity of immune cells in this autoimmune disease."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n In gastric cancer, whole-transcriptome analysis revealed that FAM66C is an integral part of a ceRNA network—specifically within the FAM66C/miR‑129‑5p/target mRNAs regulatory axis—implicating its potential involvement in chemoresistance to cisplatin."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Conversely, in pancreatic cancer, FAM66C appears to play a tumor suppressor role by directly interacting with miR‑574‑3p; its inhibition suppresses proliferation and promotes apoptosis both in vitro and in xenograft models."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n In intrahepatic cholangiocarcinoma, FAM66C is overexpressed, and its upregulation enhances cell viability, glycolysis, migration, and invasion via sponging miR‑23b‑3p to derepress targets such as KCND2, thereby promoting tumor progression."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " Moreover, in prostate cancer, high levels of FAM66C correlate with advanced tumor stage and poor prognostic features; mechanistic studies indicate that FAM66C facilitates cell proliferation by activating the EGFR‑ERK signaling pathway, in part through the inhibition of proteasome-mediated degradation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Together, these findings indicate that FAM66C is involved in critical oncogenic and tumor-suppressive pathways via ceRNA-mediated microRNA interactions and modulation of key signaling cascades. Its divergent roles in different cancer types—and its potential regulatory function in autoimmune contexts such as rheumatoid arthritis—underscore the importance of FAM66C as both a prognostic biomarker and a candidate therapeutic target.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Kai Xiao, Gang Peng "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA FAM66C regulates glioma growth via the miRNA/LATS1 signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biol Chem (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1515/hsz-2021-0333"}], "href": "https://doi.org/10.1515/hsz-2021-0333"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34954927"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34954927"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Adrià Aterido, Carlos Palacio, Sara Marsal, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel insights into the regulatory architecture of CD4+ T cells in rheumatoid arthritis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0100690"}], "href": "https://doi.org/10.1371/journal.pone.0100690"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24959711"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24959711"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Xian-Zi Yang, Lei Ma, Shu-Xian Fang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Construction of a competing endogenous RNA network and identification of potential regulatory axes in gastric cancer chemoresistance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Res Pract (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.prp.2022.153904"}], "href": "https://doi.org/10.1016/j.prp.2022.153904"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35487029"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35487029"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Jiangang Zhu, Sheng Zhu, Qiang Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA FAM66C inhibits pancreatic cancer progression by sponging miR-574-3p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Transl Cancer Res (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.21037/tcr.2020.02.24"}], "href": "https://doi.org/10.21037/tcr.2020.02.24"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35117528"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35117528"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Guang-Lin Lei, Zhi Li, Yuan-Yuan Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA FAM66C promotes tumor progression and glycolysis in intrahepatic cholangiocarcinoma by regulating hsa-miR-23b-3p/KCND2 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Environ Toxicol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/tox.23346"}], "href": "https://doi.org/10.1002/tox.23346"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34418280"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34418280"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Yimin Xie, Jie Gu, Zhenqian Qin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA FAM66C is associated with clinical progression and promotes cell proliferation by inhibiting proteasome pathway in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Biochem Funct (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cbf.3531"}], "href": "https://doi.org/10.1002/cbf.3531"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32430927"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32430927"}]}]}]}
NCBI Gene ID 440078
API
Download Associations
Predicted Functions View FAM66C's ARCHS4 Predicted Functions.
Co-expressed Genes View FAM66C's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View FAM66C's ARCHS4 Predicted Functions.

Functional Associations

FAM66C has 1,602 functional associations with biological entities spanning 5 categories (molecular profile, organism, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 23 datasets.

Click the + buttons to view associations for FAM66C from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq tissue samples with high or low expression of FAM66C gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of FAM66C gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of FAM66C gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of FAM66C gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of FAM66C gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of FAM66C gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at FAM66C gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of FAM66C gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of FAM66C gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
GEO Signatures of Differentially Expressed Genes for Diseases disease perturbations changing expression of FAM66C gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of FAM66C gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of FAM66C gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of FAM66C gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Viral Infections virus perturbations changing expression of FAM66C gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of FAM66C gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of FAM66C gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of FAM66C gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of FAM66C gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of FAM66C gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of FAM66C gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles cell types and tissues with high or low DNA methylation of FAM66C gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at FAM66C gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of FAM66C gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.